Cargando…

24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience

INTRODUCTION: Advantages of vascular closure device over manual compression include patient comfort, early mobilisation and discharge, avoidance of interruption of anticoagulation, avoidance of local compression and its sequelae and less time constraint on staff. No published Indian data exist regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinayakumar, Desabandhu, Kayakkal, Shajudeen, Rajasekharan, Sandeep, Thottian, Julian Johny, Sankaran, Prasanth, Bastian, Cicy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319010/
https://www.ncbi.nlm.nih.gov/pubmed/28228304
http://dx.doi.org/10.1016/j.ihj.2016.06.008
_version_ 1782509296475439104
author Vinayakumar, Desabandhu
Kayakkal, Shajudeen
Rajasekharan, Sandeep
Thottian, Julian Johny
Sankaran, Prasanth
Bastian, Cicy
author_facet Vinayakumar, Desabandhu
Kayakkal, Shajudeen
Rajasekharan, Sandeep
Thottian, Julian Johny
Sankaran, Prasanth
Bastian, Cicy
author_sort Vinayakumar, Desabandhu
collection PubMed
description INTRODUCTION: Advantages of vascular closure device over manual compression include patient comfort, early mobilisation and discharge, avoidance of interruption of anticoagulation, avoidance of local compression and its sequelae and less time constraint on staff. No published Indian data exist regarding Perclose Proglide suture mediated vascular closure device (SMC). AIM: To study the 24 h and 30 day outcome of Perclose Proglide SMC retrospectively. STUDY DESIGN: Retrospective observational study conducted in the Department of Cardiology, Government Medical College, Calicut, Kerala from June 2013 to June 2015. METHODOLOGY: All consecutive patients with Perclose Proglide SMC deployment done by a single operator for achieving access site haemostasis where 24 h and 30 day post-procedure data were available were included. Major and minor complications, procedure success, device failure were predefined. RESULTS: 323 patients were analysed. Procedure success rate was 99.7% (322/323). Transient oozing occurred in 44 patients (13.6%), minor and major complications occurred in 2% and 1.5% of patients respectively. Major complication included one case of retroperitoneal bleed, one access site infection, one pseudo aneurysm formation and two access site arterial stenosis. There was no death or complication requiring limb amputation. “Preclose” technique was used successfully in six patients. Primary device failure occurred in 12 cases which were tackled successfully with second Proglide in all except one. CONCLUSION: Perclose Proglide SMC is a safe and effective method to achieve haemostasis up to 22F with less complication rate.
format Online
Article
Text
id pubmed-5319010
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53190102018-01-01 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience Vinayakumar, Desabandhu Kayakkal, Shajudeen Rajasekharan, Sandeep Thottian, Julian Johny Sankaran, Prasanth Bastian, Cicy Indian Heart J Original Article INTRODUCTION: Advantages of vascular closure device over manual compression include patient comfort, early mobilisation and discharge, avoidance of interruption of anticoagulation, avoidance of local compression and its sequelae and less time constraint on staff. No published Indian data exist regarding Perclose Proglide suture mediated vascular closure device (SMC). AIM: To study the 24 h and 30 day outcome of Perclose Proglide SMC retrospectively. STUDY DESIGN: Retrospective observational study conducted in the Department of Cardiology, Government Medical College, Calicut, Kerala from June 2013 to June 2015. METHODOLOGY: All consecutive patients with Perclose Proglide SMC deployment done by a single operator for achieving access site haemostasis where 24 h and 30 day post-procedure data were available were included. Major and minor complications, procedure success, device failure were predefined. RESULTS: 323 patients were analysed. Procedure success rate was 99.7% (322/323). Transient oozing occurred in 44 patients (13.6%), minor and major complications occurred in 2% and 1.5% of patients respectively. Major complication included one case of retroperitoneal bleed, one access site infection, one pseudo aneurysm formation and two access site arterial stenosis. There was no death or complication requiring limb amputation. “Preclose” technique was used successfully in six patients. Primary device failure occurred in 12 cases which were tackled successfully with second Proglide in all except one. CONCLUSION: Perclose Proglide SMC is a safe and effective method to achieve haemostasis up to 22F with less complication rate. Elsevier 2017 2016-06-28 /pmc/articles/PMC5319010/ /pubmed/28228304 http://dx.doi.org/10.1016/j.ihj.2016.06.008 Text en © 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Vinayakumar, Desabandhu
Kayakkal, Shajudeen
Rajasekharan, Sandeep
Thottian, Julian Johny
Sankaran, Prasanth
Bastian, Cicy
24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title_full 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title_fullStr 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title_full_unstemmed 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title_short 24 h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience
title_sort 24 h and 30 day outcome of perclose proglide suture mediated vascular closure device: an indian experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319010/
https://www.ncbi.nlm.nih.gov/pubmed/28228304
http://dx.doi.org/10.1016/j.ihj.2016.06.008
work_keys_str_mv AT vinayakumardesabandhu 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience
AT kayakkalshajudeen 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience
AT rajasekharansandeep 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience
AT thottianjulianjohny 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience
AT sankaranprasanth 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience
AT bastiancicy 24hand30dayoutcomeofpercloseproglidesuturemediatedvascularclosuredeviceanindianexperience